Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03HTZ
|
|||
| Former ID |
DNC001603
|
|||
| Drug Name |
LD201t1
|
|||
| Drug Type |
Aptamer
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | L-selectin (SELL) | Target Info | . | [1] |
| KEGG Pathway | Cell adhesion molecules (CAMs) | |||
| NetPath Pathway | IL9 Signaling Pathway | |||
| IL2 Signaling Pathway | ||||
| Leptin Signaling Pathway | ||||
| Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | |||
| Cell surface interactions at the vascular wall | ||||
| WikiPathways | Human Complement System | |||
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | ||||
| Cell surface interactions at the vascular wall | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Therapeutic applications of aptamers. Expert Opin Investig Drugs. 2008 Jan;17(1):43-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.